Named on 2 rounds in the feed, most often in Biotech.
Rounds from 2022-07-20 to 2026-06-30
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Beeline Medicines A startup focused on precision therapies for autoimmune and inflammatory diseases | Series A ext. Verified against 6 sources | $126M | 2026-06-30 | [ PART ] |
BigHat Biosciences, Inc. A clinical-stage, AI-driven protein therapeutics platform company | Series B Published on thinner evidence, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $75M | 2022-07-20 | [ PART ] |